首页|铜死亡基因LIPT1在脑胶质瘤诊断及预后判断中的价值

铜死亡基因LIPT1在脑胶质瘤诊断及预后判断中的价值

扫码查看
目的 探讨铜死亡基因脂肪酸转移酶-1(LIPT1)在胶质瘤诊断及预后判断中的潜在价值.方法 利用TCGA数据库挖掘胶质瘤中 10 种铜死亡基因表达.采用IHC和qRT-PCR 检测 18 例胶质瘤患者中LIPT1 的表达.采用qRT-PCR检测LIPT1 在HEB、U87 和U251 细胞中的表达.采用ROC曲线预测LIPT1 在胶质瘤中的诊断效能.采用Kaplan-Meier生存曲线和Cox分析探索LIPT1 的预后价值.采用ssGSEA数据库评估LIPT1 对胶质瘤免疫浸润的影响.探索胶质瘤中LIPT1 与免疫学检查点、DNA甲基化位点和DNA错配修复基因之间的关系.对LIPT1 相关基因进行GO、KEGG和GSEA功能富集分析.Animal TFDB3 预测LIPT1 相关转录因子.利用GDSC数据库预测针对LIPT1 和hub基因的潜在药物.结果 LIPT1 在胶质瘤中的表达高于正常组织(3.03 vs.2.28,P<0.05).Ⅱ、Ⅲ、Ⅳ级胶质瘤的免疫评分存在差异[(1.47±0.51)vs.(4.94±1.25)vs.(9.88±1.65),P<0.05].HEB、U87 和U251 细胞LIPT1 的mRNA水平存在差异[(0.22±0.03)vs.(0.45±0.04)vs.(0.58±0.05),P<0.05].LIPT1 在胶质瘤诊断中的AUC值为 0.87.LIPT1 高表达组较低表达组OS、DSS、PFI缩短,差异有统计学意义(P<0.05).LIPT1 表达与免疫浸润改变及免疫检查点、DNA甲基化位点和DNA错配修复基因的表达存在相关性(P<0.05).FOXG1 等转录因子可能与LIPT1 结合.多西他赛等药物可能通过靶向调控LIPT1 相关hub基因治疗胶质瘤.结论 LIPT1 可能是胶质瘤的潜在生物标志物,与胶质瘤不良预后有关.
Value of cuproptosis gene LIPT1 in diagnosis and prognosis of brain gliomas
Objective To investigate the potential value of the cuproptosis gene LIPT1 in the diagnosis and prognosis of glio-ma.Methods The expression of 10 cuproptosis genes in glioma was mined using TCGA database.The expression of LIPT1 in 18 glio-ma patients was detected by IHC and qRT-PCR.The expression of LIPT1 in HEB,U87 and U251 cells was detected by qRT-PCR.ROC curve was used to predict the diagnostic efficacy of LIPT1 in glioma.Kaplan-Meier survival curve and Cox analysis were used to explore the prognostic value of LIPT1.ssGSEA database was used to evaluate the effect of LIPT1 on immune invasion of glioma.To ex-plore the relationship between LIPT1 and immunological checkpoints,DNA methylation site and DNA mismatch repair genes in glio-mas,fFunctional enrichment of LIPT1-associated genes was performed with GO,KEGG,and GSEA.Animal TFDB3 predicts LIPT1-associated transcription factors.The GSCA database was utilized to predict potential drugs targeting LIPT1 and hub genes.Results LIPT1 expression in glioma was higher than in normal tissues(3.03 vs.2.28,P<0.05).The immune scores of grade Ⅱ,Ⅲ and Ⅳ gliomas were different[(1.47±0.51)vs.(4.94±1.25)vs.(9.88±1.65),P<0.05].The mRNA levels of LIPT1 in HEB,U87 and U251 cells were different[(0.22±0.03)vs.(0.45±0.04)vs.(0.58±0.05),P<0.05].The AUC value of LIPT1 in glioma diagnosis was 0.87.The OS,DSS,and PFI in the high LIPT1 expression group were shorter than those in the low LIPT1 expression group(P<0.05).The LIPT1 expression was correlated with immune infiltration changes and the expression of immune check-point,DNA methylation site and DNA mismatch repair gene(P<0.05).Transcription factors such as FOXG1 were predicted to possi-bly bind to LIPT1.Drugs such as docetaxel might treat gliomas by tar-geting and regulating LIPT1-related hub genes.Conclusions LIPT1 may be a potential biomarker and may be associated with poor prog-nosis of glioma.

gliomalipoyltransferase 1cuproptosisbiomarker

林彦琛、徐葳、英草、刘瑞、张玉钰、代二庆、李晶晶

展开 >

300162 天津,武警特色医学中心康复医学科

300162 天津,武警特色医学中心病理科

314000,天津中医药大学研究生院

300140,天津市第四中心医院药剂科

展开 >

胶质瘤 铜死亡基因脂肪酸转移酶-1 铜死亡 生物标志物

天津市教委科研项目天津市卫生健康科技项目

2022YGYB07TJWJ2022QN100

2024

武警医学
中国人民武装警察部队后勤部卫生部

武警医学

CSTPCD
影响因子:0.747
ISSN:1004-3594
年,卷(期):2024.35(4)
  • 31